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Domestic cats are unique definitive hosts for Toxoplasma gondii, the agent of an important 
global zoonosis and one of the most intensively studied coccidia. Nevertheless, many aspects 
in particular of its intestinal development and epidemiology are yet unknown. 
 
This study showed that antibody kinetics in three cats orally inoculated with tissue cysts, 
shedding oocysts, did not differ significantly from those of three cats inoculated with sporulated 
oocysts without detectable oocyst excretion, suggesting extraintestinal parasite invasion and 
exposure to tachyzoites at an early stage of infection after inoculation with any of both parasite 
stages. Analysis of serial serum samples from 65 naturally infected client-owned cats 
documented a persisting long-term humoral immune response over months to years. Of the 
1,757 client-owned cats, presented to veterinarians in Switzerland, 42.4% had a positive 
antibody response to T. gondii with the ELISA. This was higher (56.3%) in cats with outside 
access than in those without (22.1%). In the risk factor analysis, the factors age (p<0.0001), 
gender (male: p=0.046), and outside access (p<0.0001) were independently associated with 
significantly higher ELISA values. 
 
In conclusion the results of this study not only provide a basis for future surveillance but are of 
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Hauskatzen sind einzigartige Endwirte von Toxoplasma gondii, dem Erreger einer wichtigen 
globalen Zoonose und eine der am intensivsten untersuchtesten Kokzidien. Dennoch sind viele 
Aspekte, insbesondere der intestinalen Entwicklung und Epidemiologie, noch unerforscht. 
 
In dieser Studie wurde gezeigt, dass die Antikörperkinetik bei drei Katzen, die oral mit 
Gewebezysten inokuliert wurden und Oozysten ausschieden, sich nicht signifikant 
unterscheidet von der bei drei Katzen, die mit sporulierten Oozysten inokuliert wurden, ohne 
nachweisbare Oozystenausscheidung. Dies weist auf eine extraintestinale Parasiteninvasion 
und die Exposition gegenüber Tachyzoiten in einem frühen Stadium der Infektion hin. Die 
Analyse von seriellen Seren von 65 natürlich infizierten Katzen dokumentiert eine 
persistierende humorale Langzeitimmunantwort über Monate bis Jahre. Von den 1.757 Katzen, 
die Veterinären/innen in der Schweiz vorgestellt wurden, zeigten 42,4% spezifische Antikörper 
gegen T. gondii im ELISA. Die Seroprävalenz war bei Katzen mit Freigang höher (56,3%) als 
bei Wohnungskatzen (22,1%). In der Risikofakorenanalyse war Alter (p<0,0001), Geschlecht 
(männlich: p=0,046) und Freigang (p<0,0001) unabhängig voneinander mit signifikant höheren 
ELISA-Werten assoziiert. 
 
Zusammenfassend stellen die Ergebnisse dieser Studie nicht nur eine Grundlage für die 
zukünftige Überwachung dar, sondern sie sind auch wichtig für die künftige Interpretation 
seroepidemiologischer Studien.  
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Domestic cats are the most important definitive hosts for Toxoplasma gondii, the agent of an 
important global zoonosis. Serial sera from cats orally inoculated either with T. gondii tissue 
cysts (n=3) or sporulated oocysts (n=3) and from 65 client-owned cats, plus sera from 1,757 
client-owned cats presented to veterinarians in Switzerland were analyzed for an antibody 
response to T. gondii by ELISA. Risk factors for seropositivity and prevalence were estimated 
with a generalized linear and beta regression model. The first model examined the association 
of an OD405 value as the dependent variable, with gender, age, and outside access as possible 
independent variables. In the second model, we first analyzed the data assuming a bimodal 
distribution representing two overlapping distributions of OD405 values from positive and 
negative cats, enabling the assignment of a probability of true infection status to each cat. Mean 
probabilities of true infection status across groups represent an estimate of true prevalence. 
These probabilities were then regressed against age, gender and outside access. Antibody 
kinetics in cats orally inoculated with tissue cysts, shedding oocysts, did not differ significantly 
from those of cats inoculated with sporulated oocysts without detectable oocyst excretion, 
suggesting extraintestinal parasite invasion and exposure to tachyzoites in both situations at an 
early stage of infection. Analysis of serial serum samples suggested a persisting long-term 
humoral immune response. Of the client-owned cats, 42.4% (95% confidence interval (CI): 
40.1–44.6) had a positive true infection status. This was higher (56.3% (95% CI: 53.2–59.6)) 
in cats with outside access than in those without (22.1% (95% CI: 18.9–25.4)). In the first 
model, the factors age (P<0.0001), gender (male: P=0.046), and outside access (P<0.0001) 
were independently associated with significantly higher OD405 values. In the second model, the 
probability of having a positive true infection status increased with age (P<0.0001), was higher 
with outside access (P<0.0001) and in outdoor male cats (P=0.0006). 
 
Keywords:  








• Antibody kinetics were similar in cats inoculated with Toxoplasma gondii tissue cysts 
and oocysts. 
• Naturally infected cats elicited a persisting humoral immune response against T. gondii. 
• The Swiss cat population had a positive true T. gondii infection status of 42.4%. 







1. Introduction   
 
Toxoplasma gondii is a zoonotic protozoan parasite infecting a large variety of mammals and 
birds with a global distribution (Dubey and Beattie, 1988; Tenter et al., 2000). Domestic cats 
and other Felidae are the unique definitive hosts for T. gondii, as the enteroepithelial life cycle 
and production of oocysts, which are shed with feces, can be only completed in the intestinal 
tract of these animal species (Frenkel et al., 1970; Tenter et al., 2000). Cats are primarily 
infected by predation of small mammals and birds, or by ingestion of insufficiently cooked 
meat containing Toxoplasma cysts with bradyzoites. Other possible but epidemiologically less 
important ways of infection for cats are the uptake of sporulated oocysts from the contaminated 
environment, ingestion of tachyzoites via milk and intrauterine transmission (Frenkel et al., 
1970; Dubey and Beattie, 1988; Dubey et al., 1996; Tenter et al., 2000; Powell et al., 2001). 
Experimentally, the majority of previously naïve cats shed oocysts 3 - 10 days after ingesting 
bradyzoites (Dubey and Frenkel, 1976). Parasite biology after sporozoite invasion has been less 
investigated, but several studies reported oocyst excretion in approximately 20% of cats 
infected with oocysts, with prolongated prepatent periods of more than 18 days (Wallace, 1973; 
Dubey, 2002). Freshly excreted oocysts sporulate within 1 - 21 days in the environment 
depending on oxygen exposure, temperature, humidity, as well as other factors (Dubey et al., 
1970). Sporulated oocysts containing sporozoites have a high tenacity and can be infectious for 
many years under optimal conditions (Frenkel et al., 1975). Furthermore, as in intermediate 
hosts, cats can harbor extraintestinal T. gondii stages. During the acute phase of infection T. 
gondii-tachyzoites undergo rapid asexual multiplication in potentially all types of nucleated 
cells until the host’s immune response and other factors attenuate the replication, driving the 
formation of bradyzoites-containing cysts, persisting in asymptomatic cats over years (Dubey 
and Beattie, 1988; Tenter et al., 2000; Weiss and Dubey, 2009). During the course of natural 
infections, protective long-term immunity against tachyzoite pathology is thought to be 
maintained through continuous exposure to bradyzoites and reconverted tachyzoites derived 
from the persistent infection (Skariah et al., 2010). In cats, intestinal T. gondii infections are 
usually asymptomatic or may cause, especially in young cats, mild, self-limiting diarrhea. The 
extraintestinal infection in cats is mainly asymptomatic but can sometimes result in ocular, 
pulmonary, central nervous, pancreatic, or hepatic disease and death (Dubey and Carpenter, 
1993). 
Based on the assumption of a long-term humoral immune response in cats, serological testing 
has been performed to analyze the specific T. gondii seroprevalence in cat populations 
worldwide. Multiple assays have been established, including the Sabin-Feldman dye test, 
indirect fluorescent antibody test (IFAT), latex agglutination test (LAT), modified agglutination 
test (MAT), immunoblot, and ELISA to detect specific IgM, IgG, and IgA antibodies against 
tachyzoite antigens or antigen fractions (Lappin, 2010). ELISAs targeting antibodies directed 
against the purified tachyzoite surface antigens were found to be more specific than tests using 
total tachyzoite antigen suspensions in pigs (Pardini et al., 2012). Furthermore, ELISAs based 
on tachyzoite antigens showed a higher sensitivity than PCRs on tissue samples for detecting 
T. gondii infections in mice (Reperant et al., 2009), sheep (Glor et al., 2013) and pigs (Basso et 
al., 2017).  
The dynamic of specific antibody reactions over time during experimental infection is 
immunoglobulin-specific (Lappin et al., 1989). IgM can be detected approximately 2 - 4 weeks 
post-inoculation, while specific IgG appears 1 week later (Lappin et al., 1989). Whilst IgM is 
elevated for approximately 16 weeks post-inoculation, IgG is thought to persist for life (Lappin 




The objective of this study was to analyze the antibody kinetics after experimental and natural 
infections over time, determine the seroprevalence in a client-owned Swiss cat population, as 
well as to identify potential risk factors for T. gondii infection in cats.  
 
2. Material and methods 
 
2.1. Cat sera and plasma samples  
Sera from six cats experimentally inoculated with T. gondii in 2006 during so far unpublished 
studies, conserved in the serum sample collection of the Institute of Parasitology, University of 
Zurich, Switzerland, were included in the study. The cats were raised for laboratory use in the 
experimental animal facilities of the Institute of Parasitology, University of Zurich, and were 
negative for T. gondii by coproscopical examination (T. gondii IFAT titer <1:25; coproscopical 
analysis for T. gondii negative). Three 3 month old cats (SW, TB, TS: group 1) were orally 
inoculated with tissue cysts of a T. gondii type II isolate from France produced in mice (kindly 
provided by Prof. Candolfi, Institute of Parasitology and Tropical Pathology, Faculty of 
Medicine, Strasbourg, France), and three 6 month old cats (N, S, A: group 2) with 50,000 
sporulated oocysts of a T. gondii type II European isolate. Serum samples were collected before 
and 3, 6, 9, 12, 18, 24, 31, 45 and 78 days post inoculation, and stored at -20 °C. During the 
experiment, feces were collected daily until euthanasia (3.5-5 months post inoculation) and 
analyzed by the sedimentation-flotation technique for T. gondii oocysts. After euthanasia, heart 
and diaphragm samples from all six cats were collected. Real-time PCR analysis from tissue 
was performed according to Cassaing et al. (2006) and showed a positive result in at least one 
of the two tissues in all cats which confirmed T. gondii infection. All animal experiments were 
authorized by the Cantonal Veterinary Office of Zurich, Switzerland (permission no. 
140/2003). 
Between 2011 and 2017 a total of 1,757 sera or plasma samples were collected from cats 
presented to the Small Animal Hospital of the Vetsuisse Faculty, University of Zurich (87% of 
the total number of samples) or from private practices, laboratories or small animal hospitals 
located in Switzerland (13% of the samples). The samples were submitted to the laboratories 
for different diagnostic purposes. Serial blood samples were available from 65 of the included 
cats, with a time span of at least 3 months between samples.  
All samples were stored at -20 °C until use. Data concerning the cats were collected from the 
patient records in the practice management system of the Small Animal Hospital of the 
Vetsuisse Faculty, or through the corresponding veterinarians. Age, date of sampling, gender, 
outside access, postal code and reason for admission were assessed for each cat if available. 
Cats with balcony access were defined as indoor, and cats with garden access as outdoor cats.  
 
2.2. Toxoplasma gondii ELISA 
ELISA was performed to detect specific IgG against tachyzoite surface antigens of T. gondii 
(Tg-ts-antigen). The T. gondii-tachyzoite surface-antigen (Tg-ts-antigen) was extracted using 
Triton X-100 (Sigma Aldrich, St. Louis, USA) from tachyzoites of T. gondii (Strain CH-Rab 
3962 D8/94) harvested from human foreskin fibroblast (ATCC-LGC Standards Partnership; 
CRL-1634) in vitro cultures (Minbaeva et al., 2013). The 96 well ELISA plates (NUNC 
Maxisorp, Thermo Fisher Scientific, Waltham, USA) were coated with 100 µl of Tg-ts-antigen 
(5 µl/ml) ELISA buffer I (0.1 M carbonate-bicarbonate-buffer, pH 9.6, 4° C). The ELISA plates 
were washed with ELISA-wash solution I (0.9% NaCl / 0.3% Tween 20) using an ELISA 
washing machine (Microplate Washer Tecan HydroSpeed, Tecan, Maennedorf, Switzerland) 
and blocked by adding ELISA buffer II (PBS / Tween 20 / bovine haemoglobin (Sigma 
Aldrich)). Each well was filled with 100 µl of a 1:200 dilution of sera or plasma in buffer II. 




replicates of one highly positive, three replicates of one weakly positive and two negative sera, 
as well as one serum-free conjugate control, and one substrate control. Diluted sera were 
incubated at 37 °C in a wet chamber for 1 h. A conjugate anti-cat IgG (γ-specific) produced in 
goat (KPL, Gaithersburg, USA), labeled with alkaline phosphatase, was diluted 1:1,000 with 
buffer II., Conjugate dilution (100 µl) was added and the plates were incubated. The substrate 
solution was composed of 4-nitrophenylphosphate (Sigma-Aldrich) and ELISA buffer III (0.05 
M carbonate-bicarbonate-buffer, pH 9.8, 4 °C) with a concentration of 1 mg/ml. After washing 
the ELISA plate, 100 µl of the substrate solution were added to each well and incubated at 37 
°C. The OD was analyzed at absorbance A405 nm periodically, using the ELISA plate reader 
(Multiskan RC, Thermo LabSystems, Waltham, USA). When the high positive control reached 
approximately OD405 1.5, the OD405 values were noted. To reduce interassay variation, the OD405 
values of each plate were adjusted according to the average of the three low seropositive 
controls included on every ELISA plate. 
 
2.3. Statistical analysis  
The frequency distribution of the OD405 values was assumed to be a bimodal mixture 
distribution. The probability distribution with the lower mode represents the OD405 values of 
the assumed negative cats and the probability distribution with the upper mode represents the 
assumed positive cats. The bimodal mixture distribution was analyzed as a mixture of two 
distributions taken from normal, lognormal, gamma, generalized beta and Weibull 
distributions, fitted by maximum likelihood to the same data using R [http://www.R-
project.org/].  The optimized mixture of distributions was compared via Akaike’s Information 
Criterion (AIC) (Dohoo et al., 2007). The combination of two distributions which gave the 
lowest AIC value was considered to fit the data best (Dohoo et al., 2007). This gave the most 
likely probability distributions to which negative and positive cats belonged and thus enabled a 
probability of true infection status to be assigned to each cat. Mean probabilities of the true 
infection status across groups of cats represent an estimate of true prevalence. 
Possible risk factors for high OD values and true prevalence were analyzed with generalized 
linear models (GLM) using R [http://www.R-project.org/]. The first model examined the 
association of OD405 value as the dependent variable, with gender, age, and outside access as 
possible independent variables. In the second model, the probability of positivity of each cat, 
assigned based on the results of the mixed model, was regressed against age, gender, and outside 
access. 
Factors that had a P value below 0.05 were defined as significantly associated with OD405 values 
or the probability of true positive status. Additionally, non-linear changes in OD405 values and 
the probability of true positive status with age and gender of the cats were evaluated with 
generalized additive models (GAM). Cats with and without outside access were analyzed 
independently.  
The R code for the GLM and GAM analysis is provided as a supplementary file 
(http://dx.doi.org/10.17632/vzxdw9d5xp.1). 
 
2.4. Data accessibility  













The six experimentally inoculated cats seroconverted between 2 - 3 weeks post inoculation, 
independently of whether they were inoculated with sporulated oocysts or with tissue cysts (Fig. 
1). Furthermore, no differences in the serological responses were observed in these two groups 
of cats. While cats experimentally inoculated with tissue cysts (Fig. 1A) shed oocysts within 5 
- 8 days, beginning at 4 - 7 days after inoculation, cats inoculated with oocysts (Fig. 1B) did 
not shed oocysts during the whole observation period of several months. 
The IgG level variation over time in the 65 cats with serial blood sampling (0.3-5.2 years apart) 
is displayed in Fig. 2 and presented into three groups including cats with a greater than 80% 
probability of being seropositive with a IgG level variation less than 25% in group a (n=13) 
(Fig. 2A), cats with a IgG level variation over 25% of the initial OD405 value with a greater than 
80% probability of being seropositive in the follow-up examination in group b  (n=11) (Fig. 
2B) and cats with a lower than 80% probability of being seropositive cats remaining most likely 
seronegative in group c (n=41) (Fig. 2C). In two probably seropositive cats from group b the 
IgG levels decreased over 25% of the OD405 value, however the probability of being positive 
was still above 99%; in five further seropositive cats, the absorbance values increased above 
25% over time and three initially most likely seronegative cats seroconverted between 1 - 3, 6 
- 8 and 6 - 7 years of age, and a further cat seroconverted at approximately 15 years of age (Fig. 
2B). All four initially seronegative cats had outside access. No cat which initially tested 
positive, tested negative in follow-up examinations.  
The median age (range: 0.08 - 22.01 years) of the 1,757 cats was 9 years; for 1% of the cats the 
age was unknown. Fifty-eight percent (1,024/1,757 cats) had outside access, 33% (582/1,757 
cats) were indoor-only cats, and the status “outdoor-access” was unknown for 9% (151/1,757) 
of the cats. Female and male cats accounted for 42% (732/1,757 cats) and 56% (983/1,757 cats) 
of the animals, respectively, while the gender was unknown for 2% (42/1,757) of the cats. 
Ninety-two percent (907/983 cats) of the male and 84% (613/732 cats) of the female cats were 
neutered. In total, 87% (1,520/1,757) of the cats were neutered.  
A total of 1,757 cat sera or plasma samples were examined for the presence of IgG against Tg-
ts-antigens. Based on the AIC, a mixture of lognormal and Weibull distributions was the 
optimum combination of two distributions to fit the data. This mixture of distributions had an 
AIC of -1,273.8, compared with, for example two normal distributions (AIC = -988.9), two 
lognormal distributions (AIC = -1,099.02) or two Weibull distributions (AIC = -1,162.95) (Fig. 
3). For each OD405 value the probability of the cat being a true positive could then be calculated. 
This is illustrated in Fig. 4. 
Of the client-owned cats, 42.4% (95% CI: 40.1–44.6) had a positive true infection status. This 
was higher (56.3% (95% CI: 53.2–59.6)) in cats with outside access than in those cats kept 
exclusively indoors (22.1% (95% CI: 18.9–25.4)). Estimated prevalences for indoor and 
outdoor cats plus male and female cats are given in Table 1.   
Risk factors that were independently associated with significantly higher OD405 values in the 
multiple GLM analyses of the 1,757 client-owned cats were “age” (parameter=0.05, P<0.0001), 
“gender” (male: parameter=0.26, P=0.046)), and “outside access” (parameter=1.1, P<0.0001). 
When interaction effects were analyzed, male cats with outside access had a highly significant 
increase in OD values compared with female cats with outside access (P<0.0001), whilst for 
indoor cats the significance was marginal (P=0.046). For this GLM a Weibull model was found 
to give the best description of the data. Interactions between risk factors were also examined. 
In the second model, the probability of being positive increased non-linearly with age 
(P<0.0001), was higher with outside access (P<0.0001) and in male cats with outside access 




male cats had a higher probability of being positive only if they had outside access. For cats 
with no outside access there was no statistical association between probability of positivity and 
gender. 
The factor “neutered” was analyzed in each model but was found to be insignificant and was 
removed from the analysis. For the continuous variable age, the non-linear variation in 
probability of a true positive with age is illustrated in Fig. 5. The non-linear GAM gave the best 
fit, AIC for the GLM was -20,387.8 compared with the AIC for the GAM which was -20,389.9 
(Fig. 5). With increasing age of the cats, the number of data points decreased and therefore the 
confidence interval increased.  






Interestingly, the antibody kinetics against Tg-ts-antigen of cats inoculated with Toxoplasma 
cysts or sporulated oocysts, showed no difference despite earlier described different 
prepatencies (Wallace, 1973; Dubey, 2002). This suggests that the cats are exposed to 
tachyzoites shortly after the intestinal invasion of bradyzoites or sporozoites. It was 
hypothesized that bradyzoites are probably precursors of enteroepithelial replication and 
therefore they enable a quicker intestinal development (Dubey and Lappin, 2006). In our 
experiment, none of the three cats inoculated with oocysts developed patency, which is in 
concordance with findings of other studies (Dubey, 1996). The sample size (three cats) in our 
study is small and therefore it does not allow a statistical analysis. However, this finding 
emphasizes the fact that seroconversion is not always attended by patency and therefore it does 
not allow the conclusion that all seropositive cats had at least one patent episode. 
To the authors’ knowledge, the present study is the first analyzing the immune response over 
time in client-owned cats with presumably discontinuous exposure to T. gondii. Analysis of the 
serial blood samples of the 65 cats suggested no remarkable change in ELISA values over time. 
A long-term humoral response is essential to enable analysis of prevalence via serology. This 
finding would contradict the hypothesis from Opsteegh et al. (2012), stating that the steady 
seroprevalence of cats older than 12 years is due to an equal number of cats seroconverting and 
reverting to seronegative, and is in consensus with a study from Dubey et al. (1995), observing 
that the specific IgG levels of nine cats experimentally fed T. gondii tissue cysts did not decline 
beneath the cut-off over 6 years. Additionally, a further study on stray cats captured several 
times within a 10 year observation period showed that the IgG levels did not significantly 
change over time (Afonso et al., 2006).  
The seroprevalence of antibodies against T. gondii in Swiss cats of 42% is within the range of 
other European countries: 61% in Estonia (Must et al., 2015), 36% and 21% in Portugal ( Lopes 
et al., 2008; Esteves et al., 2014), 18% in the Netherlands (Opsteegh et al., 2012), 52% in Latvia 
(Deksne et al., 2013), 47% in Romania (Györke et al., 2011), 25% in Belgium (De Craeye et 
al., 2008), 45 and 32% in Spain (Gauss et al., 2003; Miró et al., 2004), 41% in Norway (Sævik 
et al., 2015) and 41% in Finland (Must et al., 2017). However, considering the different sample 
sizes, animal sampling (e.g. average age, outside access, exposure to risk factors), test 
characteristics, and environmental factors, a direct comparison of the results in the different 
studies is difficult. 
Swiss screening programs for congenital toxoplasmosis showed a decline in seroprevalence in 
pregnant women from 1982 to 2015 (Rudin et al., 2018). Risk awareness, changes in dietary 




2018). This indicates an increased susceptibility for initial infections during pregnancy. The 
frequency of infection depends not only on the susceptibility, but also on the risk of exposure 
(Larsen and Lebech, 1994). An important source of infection in humans according to the 
European Food Safety Authority Panel on Biological Hazards 
[https://www.efsa.europa.eu/de/panels/biohaz]  is thought to be foodborne and to account for 
61% of the T. gondii infections with a broad 95% uncertainty interval of 35 to 82% in Europe 
based on expert knowledge elicitation (Hald et al., 2016; EFSA et al., 2018). Oocyst shedding 
cats are assumed to be highly epidemiologically significant for the distribution of T. gondii 
based on studies showing a high seroprevalence among vegetarians (Hall et al., 1999), a low 
prevalence in pigs (van Knapen et al., 1995) and in meat from different livestock species 
(Dubey et al., 2005; Berger-Schoch et al., 2011), as well as significantly lower seroprevalences 
on cat-free islands (Wallace, 1969; Dubey et al., 1997). Therefore, surveillance of the 
seroprevalence in cats is thought to be an important parameter to assess the risk of exposure. 
However, as shown in the present study and described previously, seroconversion may occur 
without oocyst shedding; hence not all seropositive cats have shed oocysts (Dubey et al., 1995). 
Data from Switzerland showed that the frequency of domestic cats shedding T. gondii oocysts 
was between 0.4% (Frey et al., 2012) and 0.6% (Zottler et al., 2019). 
In this study, the observed seroprevalence of 22.1% in cats with no outside access was high. 
Possible reasons are that these cats had outside access in the past, or that they were infected 
indoors through their diet, including raw meat, as well as other types of food (e.g. vegetables) 
contaminated with oocysts, or oocysts accidentally carried inside by the owners. Feeding a 
Bones and Raw Food (BARF) diet has become a popular trend as improved health, immune 
status, coat quality and longevity have been advocated by proponents (Billinghurst, 2001). 
Unfortunately, the diet of the studied cat population could not be assessed.  
Consistent with the results of the present study, outside access (Miró et al., 2004; Lopes et al., 
2008; Opsteegh et al., 2012) and age (Miró et al., 2004; Afonso et al., 2006; Opsteegh et al., 
2012) were significantly associated with T. gondii seropositivity in most other studies 
worldwide. Male cats had a marginally significantly greater OD value compared with female 
cats. The interactions demonstrated that this was mainly due to the outdoor male cats. This was 
more pronounced when analyzing the probability of infection. Male cats, whether neutered or 
intact, with outside access had a higher probability of infection, whereas there was no 
significant difference between male and female cats which were kept entirely indoors. This may 
possibly be because males are thought to have wider hunting territories than females, and thus 
a higher risk of exposure, or through more frequent re-exposure as previously described in pigs 
(Warnar, 1985; Smith et al., 1992; Basso et al., 2017). This association was previously reported 
in three other studies (Miró et al., 2004; Vollaire et al., 2005; Sævik et al., 2015).  
Bioassay in cats or mice was suggested as a possible “gold standard” method to confirm T. 
gondii infection; however, this techniques cannot be applied in all situations (e.g. on living 
animals). These are expensive, time consuming, and arguable regarding ethical and animal 
welfare aspects (Glor et al., 2013). Hence, as there is no feasible “gold standard” test able to 
clearly distinguish between infected and non-infected cats, the prevalences were calculated 
from the data on probabilities of true infection status assigned to each cat based on the 
assumption that there is a bimodal probability density, with the two models representing the 
most common OD405 values for negative and positive cats. This model reflects the reality, that 
there is no absolute certainty whether a cat is positive or not. 
There are several possible reasons for misclassification of cats as seropositive or -negative by 
ELISA. One possible explanation for false positive results in young cats (younger than 8 - 12 
weeks) is the transmission of maternally-derived antibodies (Omata et al., 1994). However, 
only a few cats in our study (15 cats, 0.85% of the cat population studied) were younger than 




with epitopes of closely related species (Gondim et al., 2017). Young cats are likely to have 
less cross-reactions than older cats, due to the lack of exposure to potential cross-reacting 
antigens. The advantage of using the conjugate anti feline IgG (γ-specific), as used in this study, 
is that it is known not to react either with cat IgA or with IgM, avoiding false positive results 
due to the low specificity of IgM tests (Konishi, 1991; Liesenfeld et al., 1997; Montoya, 2002). 
On the other hand IgM is thought to rise earlier than IgG after infection (Lappin et al., 1989; 
Omata et al., 1990). Acute infections could be misclassified as negative; nevertheless the IgG 
level rise after exposure is rapid as shown in Fig. 1. All cats were clearly seropositive 2 - 3 
weeks after inoculation, indicating that only a small number of cats could be falsely classified 
as negative.  
There are several limitations to this study. Regarding the cat population, a selection bias cannot 
be excluded, as there is no data concerning the age distribution of the current Swiss cat 
population. Young and old cats could be slightly overrepresented due to the fact that the blood 
samples were collected mostly for clinical reasons. Furthermore, as blood withdrawal is more 
likely performed in well taken care of and perhaps immunocompromised cats, a distortion of 
the seroprevalence is possible. Concerning the ELISA results, unfortunately, no “gold standard” 
reference method with 100% sensitivity and specificity is available and other methods such as 
PCR or bioassay cannot be applied in our study to verify the serological results. Another 
limitation of the current study was that potential confounders such as being fed raw meat or 
individual behavior of the cat including hunting habits, could not be assessed.  
In conclusion, our data suggest exposure to tachyzoites at the same time point after infection, 
independent of a cat’s first exposure to tissue cysts or to oocysts. Furthermore, our results 
strengthens the hypothesis of a long-term or even lifelong humoral immune response after T. 
gondii infection in cats and suggest that the T. gondii seroprevalence in cats in Switzerland is 
high (42%) and that the odds of being seropositive increase with age, are higher with outside 
access and higher in male cats with outside access. The results of the study provide a basis for 
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Fig. 1. Antibody absorbance over time of the six cats orally inoculated with Toxoplasma gondii. 
(A) Three cats (SW, TB, TS) were inoculated with T. gondii tissue cysts, and (B) three cats (N, 
S, A) were inoculated with 50,000 oocysts (X-axis: time in days, day 0 = day of inoculation; 
Y-axis: OD405 values of the T. gondii ELISA).  
 
Fig. 2. Antibody absorbance over time of the 65 cats with repetitive blood samples. (A) Cats 
with a greater than 80% probability of being seropositive with a IgG level variation less than 
25% (n=13). (B) Cats with a greater than 80% probability of being seropositive in the follow-
up examination and with a IgG level variation over 25% of the initial OD405 value (n=11). (C) 
Cats with a lower than 80% probability of being seropositive, most likely remaining 
seronegative (n=41) (X-axis: time in years, year 0 = year of first blood collection; Y-axis: OD405 
values of the Toxoplasma gondii ELISA). 
 
Fig. 3. Bimodal frequency distribution of OD405 values of client-owned cats (n=1,757) analyzed 
for antibodies (IgG) against Toxoplasma gondii tachyzoite surface antigens using ELISA (X-
axis: OD405 values; Y-axis: frequency; bars: individual cats; curved lines: mixture of lognormal 
and Weibull distributions). 
 
Fig. 4. Variation of probability of the cats being true positive for Toxoplasma gondii infection 
with the OD405 value, calculated based on the results of the mixed model (X-axis: OD value; Y-
axis: probability of true positive). 
 
Fig. 5. Non-linear changes in the probability of a true positive status with age of the cats with 
outside access, evaluated with generalized additive models (GAM). Dotted lines indicate the 
95% confidence intervals (CI), x scale indicates density of the data (X-axis: ages of the cats in 





























Table 1: Estimated true prevalence of toxoplasmosis and confidence intervals (CI) in various 







































Type of cat Prevalence (CI) 
Male 0.457 (0.426-0.487) 
Female 0.379 (0.344-0.413) 
Outside 0.563 (0.532-0.596) 
Inside 0.221 (0.189-0.254) 
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